High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO).


Journal

Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897

Informations de publication

Date de publication:
10 Jul 2020
Historique:
received: 25 11 2019
accepted: 03 07 2020
entrez: 12 7 2020
pubmed: 12 7 2020
medline: 1 6 2021
Statut: epublish

Résumé

FBLIM1 gene has been recently demonstrated to be involved in the pathogenesis of bone sterile inflammation. The aim of the study is to evaluate the prevalence of FBLIM1 gene variants in a cohort of 80 Italian patients with Chronic Non-bacterial Osteomyelitis (CNO). The coding regions of FBLIM1 gene were sequenced in a cohort of 80 patients with CNO using DNA extracted from blood lymphocytes, and PCR products were sequenced. Only rare (global MAF < 2%), coding variants detected were considered. Clinical evaluation of patients with rare variants and those without was performed. Fisher's exact test was used to compare categorical and ordinal data, and Student's t-test was used to analyze continuous data. Eighteen out of 80 patients (~ 22%) presented at least one rare coding variant in FBLIM1. Eight patients presented a variant never associated before with CNO. All patients presented classical features of CNO and no statistical difference between patients with presence of FBLMI1 variants and those without were found in terms of clinical manifestation, treatment, and outcome. Considering the high frequency of rare variants in our CNO cohort, our data seem to confirm a possible role of FBLIM1 in the pathogenesis of CNO suggesting that CNO is a disorder of chronic inflammation and imbalanced bone remodeling.

Sections du résumé

BACKGROUND BACKGROUND
FBLIM1 gene has been recently demonstrated to be involved in the pathogenesis of bone sterile inflammation. The aim of the study is to evaluate the prevalence of FBLIM1 gene variants in a cohort of 80 Italian patients with Chronic Non-bacterial Osteomyelitis (CNO).
METHODS METHODS
The coding regions of FBLIM1 gene were sequenced in a cohort of 80 patients with CNO using DNA extracted from blood lymphocytes, and PCR products were sequenced. Only rare (global MAF < 2%), coding variants detected were considered. Clinical evaluation of patients with rare variants and those without was performed. Fisher's exact test was used to compare categorical and ordinal data, and Student's t-test was used to analyze continuous data.
RESULTS RESULTS
Eighteen out of 80 patients (~ 22%) presented at least one rare coding variant in FBLIM1. Eight patients presented a variant never associated before with CNO. All patients presented classical features of CNO and no statistical difference between patients with presence of FBLMI1 variants and those without were found in terms of clinical manifestation, treatment, and outcome.
CONCLUSION CONCLUSIONS
Considering the high frequency of rare variants in our CNO cohort, our data seem to confirm a possible role of FBLIM1 in the pathogenesis of CNO suggesting that CNO is a disorder of chronic inflammation and imbalanced bone remodeling.

Identifiants

pubmed: 32650789
doi: 10.1186/s12969-020-00447-4
pii: 10.1186/s12969-020-00447-4
pmc: PMC7350626
doi:

Substances chimiques

Cell Adhesion Molecules 0
Cytoskeletal Proteins 0
FBLIM1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55

Subventions

Organisme : Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
ID : grant number RC 27/14

Commentaires et corrections

Type : CommentIn

Références

J Pediatr. 1989 Nov;115(5 Pt 1):730-4
pubmed: 2809904
PLoS One. 2017 Mar 16;12(3):e0169687
pubmed: 28301468
J Pediatr. 2002 Aug;141(2):198-203
pubmed: 12183714
Pediatr Rheumatol Online J. 2017 Dec 29;15(1):87
pubmed: 29287595
J Cell Sci. 2005 Feb 15;118(Pt 4):659-64
pubmed: 15701922
Eur J Hum Genet. 2002 Mar;10(3):217-21
pubmed: 11973628
J Rheumatol. 2014 Nov;41(11):2333-4
pubmed: 25362725
Arthritis Rheum. 2009 Apr;60(4):1152-9
pubmed: 19333943
Bone. 2006 Jan;38(1):41-7
pubmed: 16122996
Curr Opin Rheumatol. 2018 Sep;30(5):521-525
pubmed: 29912021
J Biol Chem. 2012 Jun 15;287(25):21450-60
pubmed: 22556421
Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1040-3
pubmed: 22032624
N Engl J Med. 2009 Jun 4;360(23):2426-37
pubmed: 19494218
PLoS One. 2011;6(10):e26355
pubmed: 22043318
Rheumatol Int. 2012 Feb;32(2):555-6
pubmed: 21240493

Auteurs

Adamo Pio d'Adamo (AP)

University of Trieste, Trieste, Italy.
Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34100, Trieste, Italy.

Anna Monica Bianco (AM)

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34100, Trieste, Italy.

Giovanna Ferrara (G)

University of Trieste, Trieste, Italy.

Martina La Bianca (M)

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34100, Trieste, Italy.

Antonella Insalaco (A)

Department of Pediatric Medicine, Division of Rheumatology, Bambino Gesù Children's Hospital, Rome, Italy.

Alberto Tommasini (A)

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34100, Trieste, Italy.

Manuela Pardeo (M)

Department of Pediatric Medicine, Division of Rheumatology, Bambino Gesù Children's Hospital, Rome, Italy.

Marco Cattalini (M)

Pediatric Clinic University of Brescia and Spedali Civili of Brescia, Brescia, Italy.

Francesco La Torre (F)

Pediatric Rheumatology Center, Pediatric Unit, "Giovanni XXIII", Pediatric Hospital, Bari, Puglia, Italy.

Martina Finetti (M)

Centro Malattie Autoinfiammatorie e Immunodeficenze, IRCCS "G. Gaslini", Genoa, Italy.

Clotilde Alizzi (C)

"G. Di Cristina"Children's Hospital, Palermo, Italy.

Gabriele Simonini (G)

Pediatric Rheumatology Unit, AOU Meyer, University of Florence, Florence, Italy.

Virginia Messia (V)

Department of Pediatric Medicine, Division of Rheumatology, Bambino Gesù Children's Hospital, Rome, Italy.

Serena Pastore (S)

Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34100, Trieste, Italy.

Rolando Cimaz (R)

Azienda Socio Sanitaria Territoriale (ASST) G.Pini and University of Milan, Milan, Italy.

Marco Gattorno (M)

Centro Malattie Autoinfiammatorie e Immunodeficenze, IRCCS "G. Gaslini", Genoa, Italy.

Andrea Taddio (A)

University of Trieste, Trieste, Italy. andrea.taddio@burlo.trieste.it.
Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Via dell'Istria 65/1, 34100, Trieste, Italy. andrea.taddio@burlo.trieste.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH